Abstract

Dissociated fetal rabbit brain cells were grown on petri dishes coated with collagen. Culture medium consisted of Dulbecco's Modified Eagles Medium plus 10% serum. The mitotic inhibitor 1-β- d-arabinofuranosylcytosine was added at 6 days for a 2 day period to inhibit over-growth by glial cells and fibroblasts. In some cases cultures were chronically exposed to 0.5, 1.0 or 2.0 μM betamethasone. Examination of cultures by phase microscopy and acetylcholinesterase (AChE) staining demonstrated that cultures incubated with 1.0 and 2.0 μM betamethasone contained 2–2.5 times as many neurons as compared to control cultures. Furthermore, there was an increase in the specific activities of both AChE and choline acetyltransferase (ChAT) which were proportional to the increase in neuronal cell numbers obtained from phase microscopy and ACHE staining. These results suggested that betamethasone enhanced survival of cholinergic neurons. Cultures were also examined for neuron specific γ-aminobutyric acid (GABA) uptake. Again GABA uptake was approximately 2–2.5 times as great in cultures incubated with 1–2 μM betamethasone when compared to controls. Thus, the increase in GABA uptake paralleled the increase in neurons observed by phase microscopy and AChE staining, suggesting that the survival effect of betamethasone was not specific to cholinergic neurons. While betamethasone treated cultures always contained greater numbers of neurons the percentage of neurons lost from all cultures after 2 weeks was the same. This suggested that the survival effect of betamethasone was transient and that the larger number of neurons detected at 3 weeks in betamethasone treated cultures may have been the result of larger numbers surviving during the first 1–2 weeks in culture.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.